Literature DB >> 1689705

Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames.

J Dillner1, L Dillner, G Utter, C Eklund, A Rotola, S Costa, D DiLuca.   

Abstract

Certain types of human papillomavirus (HPV), notably HPV type 16, are associated with flat or inverted proliferative lesions of the cervix uteri that can progress to malignancy. As a first step towards the serological study of the epidemiology of HPV, we have synthesized the entire amino acid sequences of the 2 major viral capsid proteins of HPV type 16, L1 and L2, as a set of 66 synthetic 20-residue peptides with an overlap of 5 amino acids. The peptides were tested for reactivity with IgA, IgG and IgM antibodies in the sera of 30 patients with HPV-16-carrying cervical neoplasms. Both IgG and IgM antibody responses were detected, but most of the reactivity found was of the IgA class. The most immunoreactive peptides were further analyzed for reactivity with sera from 22 patients with parotid gland tumors and with sera from 38 healthy individuals. The L2-encoded protein contained only one major linear epitope, which was not specific for HPV-16-carrying neoplasms. In contrast, the L1-encoded protein contained several epitopes that were regularly immunoreactive with antibodies present in the sera of patients with HPV-16-carrying cervical neoplasms, but only rarely so in the sera of patients with other tumors or of healthy individuals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689705     DOI: 10.1002/ijc.2910450326

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Epstein-Barr virus nuclear antigen 1 linear epitopes that are reactive with immunoglobulin A (IgA) or IgG in sera from nasopharyngeal carcinoma patients or from healthy donors.

Authors:  H M Cheng; Y T Foong; C K Sam; U Prasad; J Dillner
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

2.  Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles.

Authors:  Timothy D Culp; Christin M Spatz; Cynthia A Reed; Neil D Christensen
Journal:  Virology       Date:  2007-01-12       Impact factor: 3.616

Review 3.  Local immunity and the uterine cervix: implications for cancer-associated viruses.

Authors:  J K Roche; C P Crum
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 4.  Cancer of the cervix: prospects for immunological control.

Authors:  D H Davies; G A McIndoe; B M Chain
Journal:  Int J Exp Pathol       Date:  1991-04       Impact factor: 1.925

5.  Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.

Authors:  C Bleul; M Müller; R Frank; H Gausepohl; U Koldovsky; H N Mgaya; J Luande; M Pawlita; J ter Meulen; R Viscidi
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

Review 6.  Multiplicity of uses of monoclonal antibodies that define papillomavirus linear immunodominant epitopes.

Authors:  A B Jenson; M C Jenson; L Cowsert; S J Ghim; J P Sundberg
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

7.  Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured product.

Authors:  Y L Lin; L A Borenstein; R Ahmed; F O Wettstein
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

Review 8.  Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis.

Authors:  C P Crum; S Barber; J K Roche
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

9.  Sequence variation in the L1 gene of human papillomavirus type 16 from Africa.

Authors:  J E Ramesar; E P Rybicki; A L Williamson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

10.  Arsenic exposure and human papillomavirus response in non-melanoma skin cancer Mexican patients: a pilot study.

Authors:  J Alberto Rosales-Castillo; Leonor C Acosta-Saavedra; Rosantina Torres; Jesús Ochoa-Fierro; Víctor H Borja-Aburto; Lizbeth Lopez-Carrillo; Gonzalo G Garcia-Vargas; Georgina B Gurrola; Mariano E Cebrian; Emma S Calderón-Aranda
Journal:  Int Arch Occup Environ Health       Date:  2004-07-03       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.